Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Certara, Inc.

Market Cap 862M 751M 692M 651M 1.22B 81.22B 1.23B 8.24B 3.2B 40.03B 3.23B 3.17B 139B P/E 2026 *
-56.8x
P/E 2027 * -1,108x
Enterprise Value 937M 816M 752M 708M 1.32B 88.27B 1.33B 8.95B 3.48B 43.5B 3.52B 3.44B 151B EV / Sales 2026 *
2.35x
EV / Sales 2027 * 2.08x
Free-Float
69.31%
Yield 2026 *
-
Yield 2027 * -
1 day-8.13%
1 week+5.12%
Current month-4.81%
1 month+21.49%
3 months-14.77%
6 months-37.61%
Current year-37.12%
1 week 5.16
Extreme 5.16
6.24
1 month 4.47
Extreme 4.47
6.24
Current year 4.45
Extreme 4.45
10.2
1 year 4.45
Extreme 4.45
13.88
3 years 4.45
Extreme 4.45
19.87
5 years 4.45
Extreme 4.45
45.48
10 years 4.45
Extreme 4.45
45.48
Manager TitleAgeSince
Chief Executive Officer 53 2025-12-31
Director of Finance/CFO 53 2023-03-31
President 62 2023-07-31
Director TitleAgeSince
Chairman 72 2021-11-30
Director/Board Member 68 2012-12-31
Director/Board Member 59 2017-07-31
Date Insider Type Main position Quantity % Market Cap.
05-31Fiscal year

General Counsel

57,763 0.0371%
05-31Fiscal year

Head of Human Resources

16,535 0.0106%
05-13Fiscal year

Director

31,514 0.0206%
Change 5-day change 1-year change 3-year change Capi.($)
-8.13%+5.12%-47.59%-68.07% 938M
+0.13%-2.80%-21.00%+10.83% 2,815B
-1.65%-1.99%-8.21%+688.16% 313B
+14.20%+23.61%+284.67%+907.90% 123B
-0.57%+0.95%+30.50%+64.26% 107B
-1.35%-0.17%-3.82%+3.25% 88.41B
-1.60%-4.80%+71.49%+132.90% 80.67B
+0.48%+6.52%-41.37%+47.04% 55.64B
+4.93%+12.83%+0.33%+72.59% 42.34B
+7.31%+18.49%-49.80%+23.28% 34.38B
Average +1.63%+7.14%+21.52%+188.21% 366.04B
Weighted average by Cap. +0.56%-1.16%-6.03%+104.29%

Financials

2026 *2027 *
Net sales 399M 347M 320M 301M 564M 37.58B 567M 3.81B 1.48B 18.52B 1.5B 1.46B 64.18B 406M 354M 326M 307M 574M 38.26B 578M 3.88B 1.51B 18.85B 1.52B 1.49B 65.35B
Net income -16.71M -14.56M -13.42M -12.62M -23.62M -1.57B -23.78M -160M -62.01M -776M -62.72M -61.37M -2.69B -2.11M -1.84M -1.7M -1.6M -2.99M -199M -3.01M -20.18M -7.84M -98.11M -7.93M -7.76M -340M
Net Debt 74.77M 65.15M 60.06M 56.49M 106M 7.05B 106M 715M 277M 3.47B 281M 275M 12.04B -17.2M -14.98M -13.81M -12.99M -24.31M -1.62B -24.48M -164M -63.82M -799M -64.55M -63.17M -2.77B
Logo Certara, Inc.
Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical industry. It accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services, such as regulatory submissions software, natural language processing and Bayesian analytics. It offers both mechanistic and empirical biosimulation solutions, providing clients with a comprehensive offering based on their therapy goals, mechanism of action, and available data sources. Its clients include 2,600 biopharmaceutical companies, academic institutions and biotech companies across 70 countries.
Employees
1,546
Date Price Change Volume
26-06-18 5.540 $ -8.13% 7,909,790
26-06-17 6.030 $ -0.33% 4,206,863
26-06-16 6.050 $ +16.12% 7,111,920
26-06-15 5.210 $ +0.19% 4,205,619
26-06-12 5.200 $ -1.33% 3,267,330
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
5.540USD
Average target price
7.480USD
Spread / Average Target
+35.02%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CERT Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!